Items
Login
Register
Toggle Navigation
Regulation of Cannabis in FDA-Regulated Products
Quantity
Add to Cart
Back to Results
Recorded June 19, 2017 | On-Demand Webinar
With the ever-increasing number of states legalizing cannabis for medical and recreational use, many have been asking how FDA’s regulatory paradigm might apply to this burgeoning industry. During this webinar, speakers will provide an overview of the current state of regulation and explore how it intersects with FDA-regulated products. The implications for clinical research being conducted for INDs and NDAs, as well as issues related to edibles and dietary supplements, such as good manufacturing practices, will be discussed.
Jonathan A. Havens, Associate, Saul Ewing LLP
Colin Mudd, National Compliance Director, MC Management LLC
Douglas Throckmorton, Deputy Center Director for Regulatory Programs, CDER, FDA
Moderated by Emily Leongini, Associate, Arent Fox LLP
IE and Edge users: Microsoft Internet Explorer (IE) and Edge are not supported by the checkout process.
Please use Chrome, Firefox, or Safari. If you are unable to use these browsers, please contact us at 202-371-1420 or
[email protected]
and we will assist you in your purchase.
Assign Members :
Members Assigned |
Assign all contacts
Unassign all contacts
View :
All
Assigned
Unassigned
Add New Contact
Add New Contact
Cancel
Save
Assign
Full Name
Account Name
Email
Role
Total Records
- Showing Page
Discounts and special pricing for additional items will be applied once you add the item to your cart.